AllSquare Wealth Management LLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 74 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
AllSquare Wealth Management LLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$5,795
-54.6%
4,5270.0%0.00%
-57.1%
Q1 2024$12,766
-4.4%
4,5270.0%0.01%
-12.5%
Q4 2023$13,355
+16.6%
4,5270.0%0.01%
+14.3%
Q3 2023$11,453
-89.1%
4,527
-18.1%
0.01%
-89.7%
Q2 2023$104,681
+1.5%
5,5270.0%0.07%
+1.5%
Q1 2023$103,134
-13.1%
5,5270.0%0.07%
-17.3%
Q4 2022$118,720
+82.6%
5,5270.0%0.08%
+72.3%
Q3 2022$65,000
-14.5%
5,527
-3.5%
0.05%
-9.6%
Q2 2022$76,000
+15.2%
5,727
+81.1%
0.05%
+30.0%
Q1 2022$66,000
+3.1%
3,1620.0%0.04%
+8.1%
Q4 2021$64,000
-60.5%
3,162
-40.8%
0.04%
-61.9%
Q3 2021$162,000
+3.2%
5,337
-1.2%
0.10%
+5.4%
Q2 2021$157,000
-37.9%
5,402
-7.7%
0.09%
-41.0%
Q1 2021$253,000
-0.4%
5,852
+6.6%
0.16%
-8.2%
Q4 2020$254,000
+144.2%
5,490
+127.6%
0.17%
+126.7%
Q3 2020$104,000
+372.7%
2,412
+147.9%
0.08%
+294.7%
Q1 2020$22,000
-15.4%
973
-46.2%
0.02%
+5.6%
Q4 2019$26,000
+23.8%
1,810
-39.7%
0.02%
+12.5%
Q3 2019$21,000
+10.5%
3,000
+71.4%
0.02%
+14.3%
Q2 2019$19,000
+11.8%
1,7500.0%0.01%
+7.7%
Q1 2019$17,0001,7500.01%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 315,000$7,040,0003.41%
Ikarian Capital, LLC 693,716$15,505,0001.17%
EAM Global Investors LLC 71,838$1,606,0000.94%
Avidity Partners Management LP 211,000$4,716,0000.65%
MOODY ALDRICH PARTNERS LLC 79,642$1,780,0000.54%
Knoll Capital Management, LLC 20,000$447,0000.42%
EAM Investors, LLC 55,775$1,247,0000.39%
DRIEHAUS CAPITAL MANAGEMENT LLC 299,932$6,703,0000.22%
Coastal Bridge Advisors, LLC 25,014$559,0000.20%
Ikarian Capital, LLC 103,300$2,309,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders